Open Access

Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy

  • Authors:
    • Dingde Long
    • Yayu Chen
    • Liangchao Qu
    • Yang Dong
  • View Affiliations

  • Published online on: August 17, 2022     https://doi.org/10.3892/ol.2022.13467
  • Article Number: 347
  • Copyright: © Long et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

As a gynecological malignancy, endometrial cancer (EC) has a high incidence and mortality rate in women. The aim of the present study was to investigate the mechanism of EC and to identify novel effective treatment methods for this disease. The viability and proliferation of the RL95‑2 human endometrial cancer cell line were assessed using Cell Counting Kit‑8 assays. Colony formation, wound healing, Transwell, TUNEL and immunofluorescence assays were used to assess the effects of 5, 10 and 15 mM lidocaine on the colony formation, migration, invasiveness, apoptosis and Beclin 1 protein expression of RL95‑2 cells, respectively. Furthermore, western blotting was used to analyze the protein expression levels of apoptosis‑ and autophagy‑related proteins. The results demonstrated that lidocaine inhibited the viability, proliferation and migration of EC cells, and promoted apoptosis. Furthermore, lidocaine was demonstrated to induce autophagy and Beclin 1 protein expression in EC cells. In conclusion, lidocaine inhibited the proliferation and migration of EC cells, and promoted apoptosis via autophagy induction, which indicated that lidocaine may be a potential therapeutic drug for the treatment of EC.
View Figures
View References

Related Articles

Journal Cover

October-2022
Volume 24 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Long D, Chen Y, Qu L and Dong Y: Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy. Oncol Lett 24: 347, 2022.
APA
Long, D., Chen, Y., Qu, L., & Dong, Y. (2022). Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy. Oncology Letters, 24, 347. https://doi.org/10.3892/ol.2022.13467
MLA
Long, D., Chen, Y., Qu, L., Dong, Y."Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy". Oncology Letters 24.4 (2022): 347.
Chicago
Long, D., Chen, Y., Qu, L., Dong, Y."Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy". Oncology Letters 24, no. 4 (2022): 347. https://doi.org/10.3892/ol.2022.13467